DrugId:  1
1. Name:  NV-18
2. Groups:  Investigational
3. Description:  NV-18 is a product of the Novogen diphenolic synthetic analogue program that is creating drugs with diverse activities against specific types of cancer. Like phenoxodiol, NV-18 is broadly effective in the laboratory against almost all human cancer types, but NV-18 is distinctive in showing particular potency against melanoma and cholangiocarcinoma (cancer of the gall bladder).
4. Indication:  Investigated for use/treatment in solid tumors.
DrugId:  2
1. Name:  RRx-001
2. Groups:  Investigational
3. Description:  RRx-001 has been used in trials studying the treatment of Lymphomas, Brain Metastases, Cholangiocarcinoma, Colorectal Neoplasms, and Malignant Solid Tumor, among others.
4. Indication:  Not Available
